KPNA2 and ovarian cancer: A higher expression of the importin karyopherin a2 (KPNA2) in particular, has been associated with a poor prognosis of patients with pancreatic, breast, lung, prostate, colorectal, ovarian cancer as well as with brain tumours [3–10].